Last Updated on November 20, 2020 by monica chan
UK coffee chain, Costa Coffee, has launched an anti-bacterial reusable cup lid for £1 as part of a trial across 500 participating stores.
As the ongoing global Covid pandemic continues, people are getting more conscious about hygiene, therefore it is no surprise over 1,200 were sold in the first week of sale.
Editors note. COVID-19 is a virus, and anti-bacterial agents may have no effect on a virus. However, other attributes such as being washable can assist in preventing the spread.
The successful trial has led to branches nationwide due to stock them in 2021.
Not only is the reusable lid hygienic, but it’s better for the environment than regular take-away lids.
Normal coffee cup lids are usually made of hard polystyrene which is not widely recycled which means they need to be removed and binned separately, in which many are unaware and do not separate for disposal.
Costa’s anti-bacterial reusable lid is made from Polypropylene, a durable thermoplastic polymer with an anti-bacterial coating. The material is resistant to very high temperatures, making it dishwasher safe.
The lids come in red or white and are suitable for Small (12oz), Medium (16oz) and Large (20oz) takeaway cups across Costa Coffee stores, and Costa Express machines.
It also comes with a nylon drawstring pouch to ensure the lid is kept clean when not in use. All you have to do is present the reusable lid when you order, collect your coffee, then place the lid on the cup.
A Costa Coffee spokesperson said,
As the nation’s favourite coffee shop brand, we are proud of our sustainability credentials.
As we continue to drive reuse and recycling rates across our stores, we understand that not every customer will opt for a reusable cup when picking up their favourite, hand-crafted coffee, but we hope our new reusable lids will be an entry point to reuse for those customers.
They are smaller and more convenient, with the added benefit of its anti-bacterial coating to give even more peace of mind when contact is a concern. Initial sales results suggest it’s something the market has been missing and we look forward to expanding nationally in 2021, following the success of this trial.